• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

17 beta Hydroxysteroid dehydrogenase 1 "pseudogene" is differentially transcribed: still a candidate for the breast-ovarian cancer susceptibility gene (BRCA1).

作者信息

Touitou I, Cai Q Q, Rochefort H

机构信息

Unité Hormones et Cancer (U 148) INSERM, Université de Montpellier I, France.

出版信息

Biochem Biophys Res Commun. 1994 Jun 30;201(3):1327-32. doi: 10.1006/bbrc.1994.1849.

DOI:10.1006/bbrc.1994.1849
PMID:8024576
Abstract

BRCA1, the susceptibility gene for hereditary breast-ovarian cancer, is located on chromosome 17q12-21 but has not yet been identified. Two tandem oestradiol 17 beta hydroxysteroid dehydrogenase genes (17HSD) are assigned to this region. The active 17HSDII gene encodes the normal enzyme which regulates local synthesis of oestrogens, whereas 17HSDI is considered to be a pseudogene. We used reverse transcription coupled to polymerase chain reaction (RT-PCR) and found that the 17HSDI gene was also transcribed in half of the human cell lines and most of the biopsies studied, suggesting that 17HSDI could modulate normal 17HSDII activity in oestrogen target cells. We hypothesize that altered 17HSDI gene expression could lead to both hereditary and/or sporadic breast cancer by increasing local oestrogen concentration and that it is still a potential candidate for BRCA1.

摘要

相似文献

1
17 beta Hydroxysteroid dehydrogenase 1 "pseudogene" is differentially transcribed: still a candidate for the breast-ovarian cancer susceptibility gene (BRCA1).
Biochem Biophys Res Commun. 1994 Jun 30;201(3):1327-32. doi: 10.1006/bbrc.1994.1849.
2
Proliferative responses to altered 17beta-hydroxysteroid dehydrogenase (17HSD) type 2 expression in human breast cancer cells are dependent on endogenous expression of 17HSD type 1 and the oestradiol receptors.人乳腺癌细胞中对2型17β-羟基类固醇脱氢酶(17HSD)表达改变的增殖反应取决于1型17HSD和雌二醇受体的内源性表达。
Endocr Relat Cancer. 2006 Sep;13(3):875-84. doi: 10.1677/erc.1.01181.
3
A point mutation in the putative TATA box, detected in nondiseased individuals and patients with hereditary breast cancer, decreases promoter activity of the 17 beta-hydroxysteroid dehydrogenase type 1 gene 2 (EDH17B2) in vitro.在非患病个体和遗传性乳腺癌患者中检测到的假定TATA框中的一个点突变,在体外降低了17β-羟类固醇脱氢酶1型基因2(EDH17B2)的启动子活性。
Genomics. 1994 Sep 1;23(1):250-2. doi: 10.1006/geno.1994.1487.
4
Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression.
Nat Genet. 1995 Apr;9(4):444-50. doi: 10.1038/ng0495-444.
5
A 400 kb novel deletion unit centromeric to the BRCA1 gene in sporadic epithelial ovarian cancer.散发性上皮性卵巢癌中位于BRCA1基因着丝粒侧的一个400 kb新型缺失单元。
Oncogene. 1996 Feb 15;12(4):735-40.
6
Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.X染色体失活偏倚与乳腺癌和卵巢癌状态:BRCA1的X连锁修饰因子的证据
J Natl Cancer Inst. 2008 Nov 5;100(21):1519-29. doi: 10.1093/jnci/djn345. Epub 2008 Oct 28.
7
Genetic mapping of the breast-ovarian cancer syndrome to a small interval on chromosome 17q12-21: exclusion of candidate genes EDH17B2 and RARA.乳腺癌-卵巢癌综合征的基因定位至17号染色体q12-21区的一个小片段:排除候选基因EDH17B2和RARA
Hum Mol Genet. 1993 Aug;2(8):1193-9. doi: 10.1093/hmg/2.8.1193.
8
Prolactin-dependent up-regulation of BRCA1 expression in human breast cancer cell lines.
Biochem Biophys Res Commun. 1999 May 10;258(2):284-91. doi: 10.1006/bbrc.1999.0602.
9
A new polymorphism in the coding region of exon four in HSD17B2 in relation to risk of sporadic and hereditary breast cancer.17β-羟类固醇脱氢酶2(HSD17B2)基因第四外显子编码区的一种新多态性与散发性和遗传性乳腺癌风险的关系
Breast Cancer Res Treat. 2007 Nov;106(1):57-64. doi: 10.1007/s10549-006-9477-4. Epub 2007 Jan 27.
10
BRCA1 is differentially expressed in human tumor cells.BRCA1在人类肿瘤细胞中存在差异表达。
Shi Yan Sheng Wu Xue Bao. 2001 Mar;34(1):55-64.